Determination of Darunavir and Cobicistat Simultaneously Using Stability Indicating RP-HPLC Method
| Autor: | B. Hari Babu, M. Venkata Siva Sri Nalini, P. Rama Krishna Veni |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
0301 basic medicine
Chromatography Chemistry Cobicistat 030106 microbiology 010401 analytical chemistry Analytical chemistry 01 natural sciences Dosage form 0104 chemical sciences 03 medical and health sciences Stationary phase Stability indicating medicine Pharmacology (medical) Particle size General Pharmacology Toxicology and Pharmaceutics Darunavir medicine.drug |
| Zdroj: | MARMARA PHARMACEUTCAL JOURNAL. 20:293 |
| ISSN: | 1309-0801 |
| DOI: | 10.12991/mpj.20162036176 |
| Popis: | A simple, sensitive and precise stability indicating reverse phase high performance liquid chromatographic method has been developed and validated for the estimation of darunavir and cobicistat simultaneously in combined dosage form. The stationary phase used was Phenomenex C18 (150 x 4.6 mm, 5 µm particle size). The mobile phase used was a mixture of 0.1 M NaH 2 PO 4 and methanol (70:30 v/v ). Quantification was done with photodiode array detection at 260 nm over the concentration range of 80-240 µg/mL and 15-45 µg/mL for darunavir and cobicistat, respectively. The method had accuracy in the range of 100.11-100.31 % for darunavir and 99.87-99.89% for cobicistat. Darunavir and cobicistat were also subjected to acid, base, oxidation, heat and photo degradation. The degradation products obtained were well resolved from the darunavir and cobicistat with different retention times. Since the method can effectively separate the darunavir and cobicistat from its degradation products, it can be used as stability-indicating method. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|